The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $65.61 in the prior trading day, Doximity Inc (NYSE: DOCS) closed at $67.5, up 2.88%. In other words, the price has increased by $2.88 from its previous closing price. On the day, 0.96 million shares were traded. DOCS stock price reached its highest trading level at $68.49 during the session, while it also had its lowest trading level at $65.9301.
Ratios:
Our goal is to gain a better understanding of DOCS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 44.00. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On October 01, 2025, Goldman Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $64.
Evercore ISI Upgraded its In-line to Outperform on July 09, 2025, while the target price for the stock was maintained at $70.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 10 ’25 when REGINA M BENJAMIN bought 5,000 shares for $70.84 per share.
Wampler Kira Scherer sold 2,000 shares of DOCS for $140,020 on Oct 01 ’25. The Director now owns 19,839 shares after completing the transaction at $70.01 per share. On Oct 01 ’25, another insider, KIRA WAMPLER, who serves as the Director of the company, bought 2,000 shares for $70.01 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 12288717824 and an Enterprise Value of 11813581824. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 57.94, and their Forward P/E ratio for the next fiscal year is 40.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.44 while its Price-to-Book (P/B) ratio in mrq is 12.34. Its current Enterprise Value per Revenue stands at 20.035 whereas that against EBITDA is 48.435.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.40, which has changed by 0.53898764 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $40.87. The 50-Day Moving Average of the stock is -1.36%, while the 200-Day Moving Average is calculated to be 9.39%.
Shares Statistics:
The stock has traded on average 1.53M shares per day over the past 3-months and 1328900 shares per day over the last 10 days, according to various share statistics. A total of 136.53M shares are outstanding, with a floating share count of 132.50M. Insiders hold about 29.27% of the company’s shares, while institutions hold 66.48% stake in the company. Shares short for DOCS as of 1759190400 were 5206651 with a Short Ratio of 3.40, compared to 1756425600 on 4699719. Therefore, it implies a Short% of Shares Outstanding of 5206651 and a Short% of Float of 3.9.
Earnings Estimates
Doximity Inc (DOCS) is currently under the scrutiny of 17.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $0.45, with high estimates of $0.49 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.61 and $1.35 for the fiscal current year, implying an average EPS of $1.52. EPS for the following year is $1.67, with 17.0 analysts recommending between $1.89 and $1.47.
Revenue Estimates
18 analysts predict $157.33M in revenue for. The current quarter. It ranges from a high estimate of $158.3M to a low estimate of $152.7M. As of. The current estimate, Doximity Inc’s year-ago sales were $136.83MFor the next quarter, 18 analysts are estimating revenue of $180.04M. There is a high estimate of $186.4M for the next quarter, whereas the lowest estimate is $170.24M.
A total of 19 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $637.1M, while the lowest revenue estimate was $625M, resulting in an average revenue estimate of $633.46M. In the same quarter a year ago, actual revenue was $570.4MBased on 19 analysts’ estimates, the company’s revenue will be $702.53M in the next fiscal year. The high estimate is $721.4M and the low estimate is $688.37M.
